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THE effects of trifluoperazine and verapamil on brady-
kinin- and des-Arg9-bradykinin induced responses of
isolated rat duodenum and guinea-pig ileum were invest-
igated to elucidate post-bradykinin receptor events.
Verapamil and trifluoperazine inhibited bradykinin
induced relaxations and contractions and des-Arg9-
bradykinin induced contractions in rat duodenum. Brady-
kinin induced contractions of ileum were also inhibited by
trifluoperazine and. verapamil. Since non-competitive
affinity constants of trifluoperazine and verapamil for the
relaxant responses to bradykinin in duodenum and for the
contractile responses to bradykinin in ileum are different,
post-bradykinin receptor events related to calcium may be
different in ileum and duodenum. In addition, affinity
constants of bradykinin in guinea-pig ileum and rat
duodenum are also disparate suggesting the presence of
different types of bradykinin B receptors in these two
organs.
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Introduction
Bradykinin and other kinins are a family of
regulatory peptides involved in various pathophy-
siological conditions and may induce certain
pharmacological actions on smooth muscles. 1’2
Among those actions, bradykinin induced relaxa-
tion of isolated rat duodenum is interesting in terms
of its mode of action. Bradykinin has been reported
to cause dose dependent relaxation in the isolated
rat duodenum,3’4 although some difficulties in the
assessment of the relaxant responses to bradykinin
have been noted.4’5 This response to bradykinin can
be changed into a biphasic effect (relaxation
followed by contraction) by lowering calcium
content of bathing medium.
6 However, it has been
reported that high bradykinin concentration in
normal medium could also elicit a biphasic effect in
isolated rat duodenum, v As well as calcium ions,
cAMP seems to be important as an intracellular
mediator in the relaxant action of bradykinin.
Two kinds of receptors (B1 and B2) for kinins
have been characterized in various smooth muscles
and in the other tissues.
2 Based on the demonstra-
tion of two types of action, the existence of two
receptor types for kinins in isolated rat duodenum
has also been proposed. 8’9 In guinea-pig ileal
muscle, there is evidence that, although the
predominant receptor for bradykinin is the B2
subtype, the possibility of a multiplicity of B2
receptors exists in this tissue. 1’11 Recently, evidence
for the multiplicity of B2 in other tissues has also
(C) 1993 Rapid Communications of Oxford Ltd
been obtained and the presence of B3 and B4
receptors for kinins has been proposed.
12-14 More
recently, it has been suggested that B2 receptors in
rat duodenum are different from those in guinea-pig
ileum.
15
Calcium is an important intracellular mediator in
the effects of various agonists. Verapamil, a calcium
channel antagonist,
16 and trifluoperazine, a calrno-
dulin antagonist,
iv are the calcium antagonists
which have been widely used as pharmacological
tools to investigate the physiological role of calcium
ions in various tissues.
However, pharmacological properties of B2
receptors in rat duodenum and in guinea-pig ileum
have still not been elucidated in terms of their
differences. The present study was, therefore,
designed to investigate the influences of certain
calcium antagonists on the bradykinin induced
effects on isolated rat duodenum and guinea-pig
ileum in vitro.
Materials and Methods
Experimental a,imals: Adult Wistar rats (200-250 g)
and guinea-pigs (300-400 g) from local strains were
used. Animals were housed in a room with
controlled temperature (21 + 2C) and humidity
(65-70%). All animals were maintained in in-
dividual wire-bottom cages with ad libitum access to
food and water. The rats and guinea-pigs used in
the present study were fasted for 24 h before the
experiments.
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Isolated rat duodenum: Isolated rat duodenum was
prepared according to a method described previous-
ly.
is Briefly, the rats were sacrificed by a blow on
the head and exsanguinated. The proximal 2 cm of
duodenum was removed and suspended in a 10 ml
organ bath containing Krebs’ solution (pH 7.12) at
31C, aerated with a mixture of 95% O2 and 5%
COg. The composition of the atropinized Krebs’
solution was as follows (mM): NaC1 117.5, KC1 4.7,
CaCle.6H20 2.5, KHePO4 1.18, MgSO4.TH20 1.18,
NaHCO3 25.0, glucose 5.5 and atropine sulphate
0.14. Isotonic recordings were made on a recording
microdynamometer (Ugo Basile, No. 7050) con-
nected to an isotonic transducer (Ugo Basile,
No. 7006). All relaxations and contractions were
magnified six-fold and the load on the tissue was
1.0 g. Before commencing the experiments, the
isolated rat duodenum was allowed to equilibrate
for 30 min. During this time, the tissue was washed
every 5 min. After this initial incubation, dose-
response relationships were obtained for bradykinin
and des-Arg9-bradykinin in the absence and in the
presence of the calcium antagonists, verapamil and
trifluoperazine.
Isolatedguinea-pig ileum: Isolated guinea-pig ileum was
prepared in a manner consistent with a previous
method. TM Assays were performed on the terminal
ileum preparations taken from male guinea-pigs.
After sacrifice, the abdomen was opened and 2-3 cm
long pieces proximal to the ileocaecal sphincter
were taken. Pieces of ileum were suspended in a
10ml organ bath filled with Krebs’ solution
(pH 7.12) at 31C, gassed with a mixture of 95%
O2 and 5% CO2. For recording, tissues were
connected to the isotonic transducer mentioned
above. Contractions elicited by bradykinin were
displayed on recording microdynamometer (Ugo
Basile, No. 7050) with a five-fold magnification.
The suspended ileum was maintained under a 1.0
resting tension for a 1 h stabilization period while
the tissue was rinsed every 5 min. After this initial
incubation, dose-response curves to bradykinin
were constructed in the absence and presence of
verapamil or trifluoperazine.
Administration of doses: Non-cumulative dose-
response curves were obtained for bradykinin in the
isolated rat duodenum and guinea-pig ileum. In the
rat duodenum, administration of bradykinin doses
(1.0 x 10
-l to 6.4 x 10
-9 M) were made at 5 min
intervals with 30-65 s of contact time. After a 4 h
incubation period, non-cumulative dose-response
relationships for des-Arg9-bradykinin were also
obtained by administration of a dose range of
9.0 10 -s to 1.4 x 10-6M, since a specific
sensitization for contractile responses of the rat
duodenum to des-Arg9-bradykinin and bradykinin
has been reported,
is A 15 min dose interval for
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des-Arg9-bradykinin was used to avoid desensitiza-
tion. In isolated guinea-pig ileum, administration of
bradykinin doses (5.0 x 10
-9 to 1.6 x 10-7 M)
were made at 10 min intervals with 45-60 s of
contact time. After two reproducible dose-response
relationships were obtained for the agonists, the
calcium antagonists, verapamil and trifluoperazine,
were added to the bathing media and the tissues
were incubated with these drugs for 30 min. After
this incubation, the same dose-response procedhres
were repeated for each agonist in the presence of
verapamil or trifluoperazine. In each experiment,
only one concentration of an antagonist was
tested against one agonist.
Analysis of data and statistics" Contractions and
relaxations in the isolated tissues were expressed as
a percentage of the corresponding maximal
response to each agonist. To evaluate the relaxant
and contractile effect, pD2 values (apparent agonist
affinity constants) of bradykinin and des-Arg9-
bradykinin were calculated, while pD’2 values
(non-competitive antagonist affinity constant) were
used in the pharmacological evaluation of the
antagonistic effects of trifluoperazine and ver-
apamil. 19’2 Regression analyses were also applied in
order to examine parallelism between the non-
cumulative dose-response curves obtained in the
absence and presence of the antagonists used.
21
Values reported represent the mean-+-S.E.M.
(standard error of mean) of the results of individual
experiments. Significance of differences was de-
termined by the Student’s t-test for paired data.
22
All calculations were made by using a computer
program written in BASIC language.
23
Drugs: The following drugs were used: bradykinin
triacetate, des-Arg9-bradykinin and trifluoperazine
hydrochloride, all purchased from Sigma Chemical
Co. (St. Louis, USA) and verapamil hydrochloride,
obtained from Knoll (Germany). Solutions of
non-peptide drugs were freshly prepared in 0.9%
NaC1 before use. Several concentrations of each
peptide solution were made immediately prior to
each experiment and kept at 4C until administra-
tion, at which time the temperature of the solution
was allowed to equilibrate to 20C. Bradykinin was
dissolved in fresh saline, while des-Arg9-bradykinin
solution was prepared in 0.83 M acetic acid. Vehicle
(acetic acid) control response was checked in
isolated rat duodenum. Acetic acid in the dilutions
used did not affect the tissue responses. All drugs
were added to the organ bath in a volume not
exceeding 0.05 ml.
Results
Isolated rat duodenum.: In isolated rat duodenum,
bradykinin (1.0 x 10-1 to 6.4 x 10
-9 M) (Fig. 1A)Bradykinin receptors and their post-receptor events
]
rain
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FIG. 1. Typical responses to bradykinin and des-Arg9-bradykinin of
isolated guinea-pig ileum and rat duodenum, a, relaxant effect of brady-
kinin (3.2 x 10-9 M); b, contractile effect of bradykinin (1.6 x 10-7 M);
c, contractile effect of des-Arg9-bradykinin (3.2 x 10-7 M) on the rat
duodenum; d, contractile effect of bradykinin (1.7 x 10-7 M) on the
guinea-pig ileum.
and des-Argg-bradykinin (9.0 x 10-7 to 6.4 x
10-6 M) (Fig. 1C) elicited dose dependent relaxa-
tions and contractions, respectively. Bradykinin
also induced a dose dependent contractile effect on
the rat duodenum (Fig. 1B). The dose cycles used
did not cause any desensitization to either
bradykinin or des-Arg9-bradykinin, pD2 values for
the relaxant and contractile effects of bradykinin and
des-Arg9-bradykinin are listed in Table 1. Bradyki-
nin induced relaxations and contractions and
des-Arg9-bradykinin induced contractions in the rat
duodenum were antagonized by trifluoperazine and
verapamil, non-competitively (Figs. 2 and 3). pD’2
values for the dose dependent antagonistic effects
of trifluoperazine and verapamil are shown in Table
2.
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FIG. 2. Inhibitory effects of verapamil (A,C) and trifluoperazine (B,D) on the relaxant (A,B) and contractile (C,D) responses of isolated rat duodenum
to bradykinin. BK, bradykinin; Ver, verapamil’ TFP, trifluoperazine; vertical bars indicate standard error of mean (+S.E.M.).
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Table 1. Apparent affinity constants (pD2 values) for the effects
of bradykinin and des-ArgS-bradykinin in the isolated rat
duodenum and guinea-pig ileum
Agonist Rat duodenum Guinea-pig ileum
Bradykinin
Relaxant response 9.83 _+_ 0.02 N.A.*
(n 10)
Contractile response 7.30 +_ 0.05** 7.50 +__ 0.01
(n 10) (n 20)
Des-Arg9-bradykinin 6.59 -I- 0.07 N.A.*
(n 10)
Values represent mean (+__S.E.M.) of individual results. The
values in the parentheses indicate the number of experiments.
Bradykinin and des-Arg9-bradykinin did not elicit reproducible
relaxations of rat duodenum and contractions of guinea-pig
ileum, respectively. **p < 0.001 and ***p < 0.005 significances
relative to the relaxant response of rat duodenum induced by
bradykinin, respectively.
Isolated guinea-pig ileum: Bradykinin (2.5 x 10-9 to
1.7 x 10-7 M) caused dose dependent and slow
onset contractions of the isolated guinea-pig ileum
(Fig. 1D). No desensitization was observed for this
effect with the dose cycle used in this study. The
pD2 value for the contractile effect of bradykinin
on the guinea-pig ileum is given in Table 1.
Trifluoperazine and verapamil inhibited bradykinin
induced contractions of isolated guinea-pig ileum
in a non-competitive manner (Fig. 4). The
inhibitory effects of trifluoperazine and verapamil
were also dose dependent in nature, pD’2 values
concerning their inhibitory effects are summarized
in Table 2.
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FIG. 3. Inhibitory effects of verapamil (A) and trifluoperazine (B) on the contractile responses of isolated rat duodenum to des-Argg-bradykinin. DABK,
des-Arg -bradykinin; Ver, verapamil; TFP, trifluoperazine; vertical bars indicate standard error of mean (_S.E.M.).
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FIG. 4. Inhibitory effects of verapamil (A) and trifluoperazine (B) on the contractile responses of isolated guinea-pig ileum to bradykinin. BK, bradykinin;
Ver, verapamil; TFP, trifluoperazine; vertical bars indicate standard error of mean (+S.E.M.).
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Table 2. Non-competitive affinity constants (pDz values) for
the antagonistic effects of trifluoperazine and verapamil on
bradykinin and des-Argg-bradykinin induced relaxations and
contractions in the isolated rat duodenum and guinea-pig ileum
Agonist Trifluoperazine Verapamil*
Agonist Trifluoperazine Verapamil*
Isolated rat duodenum
Bradykinin (Relaxant R)
Bradykinin (Contractile R)
Des-Arg9-bradykinin
Isolated guinea-pig ileum
Bradykinin
4.99 + 0.02** 6.48 ___
0.07
(n=7) (n=8)
6.87 _+ 0.08 6.55 _+ 0.05
(n=8) (n=7)
6.90 + 0.02 6.40 __+ 0.06
(n=8) (n=7)
6.96 + 0.04 6.44 _+ 0.09
(n=9) (n=7)
Values represent mean (+S.E.M.) of individual results. The
values in the parentheses indicate the number of experiments.
*No significant differences between the pDz values (p < 0.1 ).
**p < 0.005 relative to the other pD, values.
Discussion
This study shows that the mechanisms of the
contractile and relaxant effects of bradykinin in
isolated rat duodenum and guinea-pig ileum are
different in regard to their dependency on cellular
calcium metabolism. Isolated guinea-pig ileum is
the most extensively investigated smooth muscle in
terms of bradykinin effects. It has been long known
that bradykinin produces a slow biphasic contrac-
tion in isolated guinea-pig ileum, contrasting with
the quick, almost instantaneous effects elicited by
histamine and acetylcholine.4’5 A relaxant effect of
bradykinin has been also reported in the isolated
guinea-pig ileum precontracted with acetylcholine.
This effect of bradykinin in guinea-pig ileum has
been found to be inhibited by phentolamine
% which
has been demonstrated to have calcium antagonistic
properties.
7 Attempts have been made since the late
1970s to classify the kinin receptors in the
guinea-pig ileum as well as in the other tissues from
certain animal species. According to the current
classification, B. receptors are the predominant
receptors for the effect of bradykinin in the
guinea-pig ileum, whereas B1 receptors seem to be
absent in this tissue,e’11 On the other hand, it has
been suggested that bradykinin induced contraction
and relaxation of rat duodenum are mediated by B1
and Be receptors, respectively. 8’9 Des-Arg9-bradyki
nin is also effective in the isolated rat duodenum
indicating the presence of B1 receptors. In recent
years, the evidence for the multiplicity of Be
receptors has accumulated from studies using
isolated gastrointestinal preparations as well as
other tissues.’2 In fact, the existence of two more
receptors (B3 and B4) in various tissues has been
proposed. 13’14’28 Furthermore, it has been suggested
that Be receptors in the rat duodenum might be
different from those in guinea-pig ileum.
15 Since the
pD2 value for the contractile effect of bradykinin in
isolated guinea-pig ileum was found to be different
from that for the relaxant effect of bradykinin in
the isolated rat duodenum (Table 1), it might be
thought that B2 receptors are different in these two
tissues.
From the findings obtained in this study,
post-receptor regulatory events also seem to be
different in isolated guinea-pig ileum and rat
duodenum. Calcium ions are important in the
relaxant and contractile effects of bradykinin and
des-Arg9-bradykinin in these gastrointestinal
smooth muscles. Calcium has been known to play
an important role in the signal transduction
mechanisms for the bradykinin effects in various
tissues. 11’14’e8 Contractile responses of guinea-pig
ileum and rat duodenum to bradykinin and
des-Arg9-bradykinin were inhibited by verapamil
and trifiuoperazine. Verapamil is known as a
calcium entry blocking agent in the concentration
range used by us.
6 This implies that a calcium flu
via voltage dependent channels from the extra-
cellular space towards the cytoplasm contribute to
the bradykinin- and des-Arg9-bradykinin induced
contraction. Intracellular calcium may also play a
role in the contraction caused by bradykinin as
observed in various smooth muscles. 14’28’29 In that
case, the formation of inositol phosphates, in
particular inositol 1,4,5-triphosphate, on stimula-
tion of bradykinin sensitive receptors is thou_ght to
release calcium from the endoplasmic reticulum to
trigger the contractile elements. This calcium
compartment is most likely filled with cytoplasmic
reticulum by a calmodulin dependent calcium
pump.
3-32 Thus, trifluoperazine induced inhibition
of this process which stores calcium by interfering
with calcium pumping, results in a reduced calcium
release upon bradykinin B2 receptor stimulation,
since trifiuoperazine is reported to inhibit calmodu-
lin in the concentration range used by us.7
Therefore, both influx of the extracellular calcium
and release of the intracellular calcium seem to play
an important role in the bradykinin induced
contraction of isolated guinea-pig ileum via B2
receptors. The mechanism for the contractile effect
of des-Argg-bradykinin in the isolated rat duode-
num might occur in a similar manner, but the
receptors involved in the calcium dependent
contractile effect of 9 des-Arg -bradykinin areB type
receptors for kinins.
The inhibitory effects of verapamil may not be
related to their nonspecific effects. Verapamil, but
not nifedipine, have been reported to inhibit
calmodulin stimulated Cae+-Mg2+-ATPase in the
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concentrations higher than 10
-3 M. 33’34 However,
such a mechanism seems unlikely in the antagonistic
action ofverapamil against bradykinin and des-Arg9-
bradykinin, because the concentration required for
this antagonism is approximately 100 times lower
than that required for the Ca2+-Mg2+-ATPase
inhibition. Phenothiazines including trifluoperazine
possess well-known dopamine antagonistic
35 and
anticholinergic
36 properties, especially in the central
nervous system, which seem to be responsible for
their antipsychotic activities. This effect may occur
only in the central nervous system and at a plasma
concentration as low as 30 ng/ml which is also
decreased during the passage through the blood-
brain barrier.37 Therefore, these two mech-
anismsseem unlikely in the inhibitory activity of
trifluoperazine against bradykinin and des-Arg9-
bradykinin.
On the other hand, adenylate cyclase activation,
and the consequent increase in cAMP are involved
in the relaxant effect of bradykinin on isolated rat
duodenum4 as well in its effect in fibroblasts.
38 In
the authors’ laboratory, it was also observed that
nicotinic acid, an adenylate cyclase inhibitor,
39
causes a non-competitive inhibition of relaxant
action of bradykinin in isolated rat duodenum
((3ztrk Y, unpublished results). Bradykinin
induced relaxation of the rat duodenum is also
dependent on extracellular calcium content.6’4 The
increase in the intracellular cAMP level by
bradykinin may involve in turn phospholipid
methylation, calcium flux, phospholipase A2 activa-
tion and prostaglandin formation.
38 It is well known
that the activity of adenylate cyclase is modulated
by calcium concentration.
41 Hence, the inhibition of
the bradykinin induced relaxation by trifluoperazine
and verapamil shows that both calcium and
calmodulin are involved in this process as well.
In conclusion, the findings obtained in the
present study strongly suggest that the post-
receptor events activated by bradykinin in the
isolated guinea-pig ileum and rat duodenum may
be different, as the inhibitory profiles of the calcium
antagonists in these two tissues are not identical.
Furthermore, there is a high likelihood that
bradykinin B2 receptors in the guinea-pig ileum and
rat duodenum represent different receptor subtypes,
since the apparent receptor affinity constants of
bradykinin obtained from these two tissues are not
of the same magnitude.
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